La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
Luye Pharma Group Gestion
Gestion contrôle des critères 3/4
We currently do not have sufficient information about the CEO.
Informations clés
Dian Bo Liu
Directeur général
CN¥4.2m
Rémunération totale
Pourcentage du salaire du PDG | 75.1% |
Durée du mandat du directeur général | 21.1yrs |
Propriété du PDG | n/a |
Durée moyenne d'occupation des postes de direction | 12.6yrs |
Durée moyenne du mandat des membres du conseil d'administration | 10.2yrs |
Mises à jour récentes de la gestion
Recent updates
Luye Pharma Group Ltd.'s (HKG:2186) Earnings Haven't Escaped The Attention Of Investors
Jun 19We Discuss Why Luye Pharma Group Ltd.'s (HKG:2186) CEO Compensation May Be Closely Reviewed
May 21Here's Why Luye Pharma Group (HKG:2186) Has A Meaningful Debt Burden
Apr 26Is Luye Pharma Group Ltd. (HKG:2186) Trading At A 27% Discount?
Feb 29Some Confidence Is Lacking In Luye Pharma Group Ltd.'s (HKG:2186) P/S
Jan 09Luye Pharma Group (HKG:2186) Takes On Some Risk With Its Use Of Debt
Dec 19A Look At The Fair Value Of Luye Pharma Group Ltd. (HKG:2186)
Nov 24Is Luye Pharma Group (HKG:2186) A Risky Investment?
Sep 12Luye Pharma Group Ltd.'s (HKG:2186) Intrinsic Value Is Potentially 20% Below Its Share Price
Aug 17Is Luye Pharma Group (HKG:2186) Using Too Much Debt?
May 10We Think Luye Pharma Group (HKG:2186) Is Taking Some Risk With Its Debt
Sep 20Time To Worry? Analysts Just Downgraded Their Luye Pharma Group Ltd. (HKG:2186) Outlook
Apr 06Luye Pharma Group's (HKG:2186) Shareholders Are Down 31% On Their Shares
Mar 17A Closer Look At Luye Pharma Group Ltd.'s (HKG:2186) Impressive ROE
Feb 19Analyse de la rémunération des PDG
Date | Rémunération totale | Salaire | Bénéfices de l'entreprise |
---|---|---|---|
Dec 31 2023 | CN¥4m | CN¥3m | CN¥533m |
Sep 30 2023 | n/a | n/a | CN¥495m |
Jun 30 2023 | n/a | n/a | CN¥458m |
Mar 31 2023 | n/a | n/a | CN¥531m |
Dec 31 2022 | CN¥3m | CN¥3m | CN¥605m |
Sep 30 2022 | n/a | n/a | CN¥190m |
Jun 30 2022 | n/a | n/a | -CN¥224m |
Mar 31 2022 | n/a | n/a | -CN¥179m |
Dec 31 2021 | CN¥4m | CN¥3m | -CN¥134m |
Sep 30 2021 | n/a | n/a | CN¥210m |
Jun 30 2021 | n/a | n/a | CN¥554m |
Mar 31 2021 | n/a | n/a | CN¥630m |
Dec 31 2020 | CN¥5m | CN¥4m | CN¥707m |
Sep 30 2020 | n/a | n/a | CN¥955m |
Jun 30 2020 | n/a | n/a | CN¥1b |
Mar 31 2020 | n/a | n/a | CN¥1b |
Dec 31 2019 | CN¥4m | CN¥3m | CN¥1b |
Sep 30 2019 | n/a | n/a | CN¥1b |
Jun 30 2019 | n/a | n/a | CN¥1b |
Mar 31 2019 | n/a | n/a | CN¥1b |
Dec 31 2018 | CN¥4m | CN¥3m | CN¥1b |
Sep 30 2018 | n/a | n/a | CN¥1b |
Jun 30 2018 | n/a | n/a | CN¥1b |
Mar 31 2018 | n/a | n/a | CN¥1b |
Dec 31 2017 | CN¥4m | CN¥3m | CN¥981m |
Rémunération vs marché: Dian Bo's total compensation ($USD585.65K) is about average for companies of similar size in the Hong Kong market ($USD629.60K).
Rémunération et revenus: Dian Bo's compensation has increased by more than 20% whilst company earnings have fallen more than 20% in the past year.
PDG
Dian Bo Liu (58 yo)
21.1yrs
Titularisation
CN¥4,180,000
Compensation
Mr. Dian Bo Liu is a Co-Founder of Luye Pharma Group Ltd. in 1994 and serves as its Head of Corporate Directions & Strategies and has been its Chief Executive Officer since July 2003. Mr. Liu is responsibl...
Équipe de direction
Nom | Position | Titularisation | Compensation | Propriété |
---|---|---|---|---|
Co-Founder | 21.1yrs | CN¥4.18m | pas de données | |
Co-Founder & Vice Executive Chairman | 21.1yrs | CN¥3.09m | pas de données | |
Co-Founder & Executive Director | no data | CN¥1.46m | pas de données | |
Executive Director | no data | CN¥1.50m | pas de données | |
Chief Financial Officer | 12.6yrs | pas de données | pas de données | |
Company Secretary | 3.7yrs | pas de données | pas de données |
12.6yrs
Durée moyenne de l'emploi
58yo
Âge moyen
Gestion expérimentée: 2186's management team is seasoned and experienced (12.6 years average tenure).
Membres du conseil d'administration
Nom | Position | Titularisation | Compensation | Propriété |
---|---|---|---|---|
Co-Founder | 21.1yrs | CN¥4.18m | pas de données | |
Co-Founder & Vice Executive Chairman | 21.1yrs | CN¥3.09m | pas de données | |
Co-Founder & Executive Director | 21.1yrs | CN¥1.46m | pas de données | |
Executive Director | 10.4yrs | CN¥1.50m | pas de données | |
Independent Non-Executive Director | 10.2yrs | CN¥269.00k | pas de données | |
Independent Non-Executive Director | 10.2yrs | CN¥322.00k | pas de données | |
Non-Executive Director | 7.4yrs | CN¥269.00k | pas de données | |
Independent Non-Executive Director | 10.2yrs | CN¥269.00k | pas de données | |
Independent Non-Executive Director | 10.2yrs | CN¥269.00k | pas de données | |
Non-Executive Director | less than a year | pas de données | pas de données | |
Independent Non-Executive Director | 1.3yrs | CN¥162.00k | pas de données |
10.2yrs
Durée moyenne de l'emploi
61yo
Âge moyen
Conseil d'administration expérimenté: 2186's board of directors are seasoned and experienced ( 10.2 years average tenure).